Review Panels
Cross-source consensus on Review Panels from 1 sources and 5 claims.
1 sources · 5 claims
Other
Other
Other
Highlighted claims
- Two review panels assess the messages, one made up of primary care providers and one made up of primary care patients. — A double-blind, crossover, non-inferiority randomised controlled trial where primary care providers and patients compare human-generated and AI-generated digital health messages: the AI-CARE study protocol
- The target panel size is 24 providers and 24 patients. — A double-blind, crossover, non-inferiority randomised controlled trial where primary care providers and patients compare human-generated and AI-generated digital health messages: the AI-CARE study protocol
- The study aims for at least 20% of each panel to have French as the language most spoken at home. — A double-blind, crossover, non-inferiority randomised controlled trial where primary care providers and patients compare human-generated and AI-generated digital health messages: the AI-CARE study protocol
- Patient panellists must be adults who can consent and are proficient in written English or French. — A double-blind, crossover, non-inferiority randomised controlled trial where primary care providers and patients compare human-generated and AI-generated digital health messages: the AI-CARE study protocol
- Participants lacking the technology needed for online REDCap evaluations are excluded. — A double-blind, crossover, non-inferiority randomised controlled trial where primary care providers and patients compare human-generated and AI-generated digital health messages: the AI-CARE study protocol